在布朗大学和罗德岛的儿科内分泌学史
Philip A Gruppuso1, Lisa Swartz Topor2, Jose Bernardo Q Quintos3
1Professor of Pediatrics, Professor of Medical Science, The Warren Alpert Medical School of Brown University, Providence, RI.
Rhode Island medical journal (2013)
|November 24, 2025
概括
布朗大学儿科内分泌学科成立于1967年,为儿科内分泌疾病提供全面的护理. 它有着悠久的研究历史,并培养了31名儿科内分泌学专家.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 代谢和生物化学研究.
背景情况:
- 布朗大学儿科内分泌学科起源于代谢和生物化学研究.
- 该部门成立于1967年,具有丰富的历史,包括自1974年以来对儿科糖尿病的专业知识.
- 儿科内分泌和新陈代谢统一部门于1987年成立.
研究的目的:
- 概述布朗大学儿科内分泌学科的历史发展和当前服务.
- 为了突出该部门对研究和临床培训的承诺.
- 描述为提供儿童内分泌疾病护理的多学科团队.
主要方法:
- 对该部门的建立和关键里程碑的历史回顾.
- 描述教师,研究员和工作人员的组成.
- 对提供给儿童和青少年的临床服务的概述.
主要成果:
- 该部门已经毕业了31名经过董事会认证的儿科内分泌科医生.
- 它目前由八名教师,三名研究员和15名辅助人员组成.
- 针对各种内分泌疾病,包括糖尿病,提供全面的多学科临床服务.
结论:
- 布朗大学儿科内分泌学科有着长期的研究和临床卓越的传统.
- 该部门配备齐全,能够为儿科内分泌和代谢疾病提供全面的护理.
- 它的历史反映了致力于推进该领域和培养未来专家的奉献精神.
相关概念视频
Smooth Endoplasmic Reticulum
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...


